UPC vs BIOA

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 23, 2026

UPC

38.2
AI Score
VS
BIOA Wins

BIOA

54.8
AI Score

Investment Advisor Scores

UPC

38score
Recommendation
SELL

BIOA

55score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric UPC BIOA Winner
Forward P/E 0 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth -1.3% 1.6% BIOA
Earnings Growth -82.0% 0.0% BIOA
Tradestie Score 38.2/100 54.8/100 BIOA
Profit Margin -10.9% 0.0% BIOA
Beta 1.00 1.00 Tie
AI Recommendation SELL HOLD BIOA

Relative Price Performance (Last 90 Days)

UPC 1M: +39.8% · 3M: +97.0% BIOA 1M: -56.7% · 3M: -43.4%

Current Technical Phase

UPC

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (23.0% over 20 days), RSI 51

RSI (14): 50.6 · Price: $5.30

BIOA

Markdown
Sell / avoid

Price below a falling SMA50 (slope -7.4%), weak momentum, RSI 30

RSI (14): 29.8 · Price: $9.48

Fundamentals Snapshot

Metric UPC BIOA
Market Cap
Forward P/E 0.0 -4.0
Trailing P/E
Revenue (TTM)
Revenue Growth 0.0% 0.0%
Gross Margin 0.4% -7.5%
Operating Margin -0.2% -12.0%
EPS -1.25 -2.15
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, BIOA is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.